Loading...
XNAS
HCAT
Market cap183mUSD
Dec 05, Last price  
2.60USD
1D
-3.35%
1Q
-23.08%
IPO
-93.21%
Name

Health Catalyst Inc

Chart & Performance

D1W1MN
XNAS:HCAT chart
P/E
P/S
0.60
EPS
Div Yield, %
Shrs. gr., 5y
26.28%
Rev. gr., 5y
14.62%
Revenues
307m
+3.60%
73,081,000112,574,000154,941,000188,845,000241,926,000276,236,000295,938,000306,584,000
Net income
-70m
L-41.17%
-47,035,000-61,984,000-60,096,000-115,017,000-153,210,000-137,403,000-118,147,000-69,502,000
CFO
15m
P
-36,829,000-40,296,000-32,184,000-26,148,000-23,123,000-35,270,000-33,080,00014,559,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

Health Catalyst, Inc. provides data and analytics technology and services to healthcare organizations. Its offerings include data and analytics platform, a commercial-grade data and analytics platform for the healthcare sector; AI and data science, providing integration of AI into existing business intelligence tools, increasing analytics accuracy; population health management identifies improvement across the care continuum as well as actionable guidance for success and automated workflows; financial transformation providing costing and labor productivity insights and revenue capture; quality and safety improvement using clinical quality and patient safety data, analytics, and expert services; and national data ecosystem for thought leadership and mutual knowledge exchange to transform care delivery through next-gen insights. The company was formerly known as HQC Holdings, Inc. and changed its name to Health Catalyst, Inc. in March 2017. Health Catalyst, Inc. was founded in 2008 and is based in South Jordan, Utah.
IPO date
Jul 25, 2019
Employees
1,200
Domiciled in
US
Incorporated in
US

Valuation

Title
USD in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFY
2024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT